GPhC fails FtP timeliness evaluation again as performance ‘deteriorates’
The time taken by the General Pharmaceutical Council (GPhC) to resolve FtP cases “deteriorated” in 2023/24, the Professional Standards Authority (PSA) has found in its performance review of the regulator.
